Research and development activities of the employees of SIC Eco-safety LLC, of course, are not limited only to clinical studies. The Journal of Pharmacotherapy Safety and Risk published an original article on optimizing approaches to adverse event analysis in clinical bioequivalence studies. The authors are A.B. Verveda, V.B. Vasilyuk, G.I. Syraeva and M.V. Faraponova conducted an original study based on more than 10 years of experience in conducting clinical bioequivalence studies and in-depth analysis of the literature on mathematical modeling and pharmacosafety issues.
The article can be accessed at https://www.risksafety.ru/jour/article/view/374/993
To cite
Verveda A.B., Vasilyuk V.B., Syraeva G.I., Faraponova M.V. Optimization of approaches to the analysis of adverse events in clinical bioequivalence studies. Safety and risk of pharmacotherapy. 2023;. https://doi.org/10.30895/2312-7821-2023-374
Verveda A.B., Vasilyuk V.B., Syraeva G.I., Faraponova M.V. Optimization of Approaches to Adverse Event Analysis in Bioequivalence Clinical Trials. Safety and Risk of Pharmacotherapy. 2023;. https://doi.org/10.30895/2312-7821-2023-374
